News & Events

Caris Life Sciences™, a leading biosciences company focused on driving precise and personalized healthcare, has moved to a new corporate headquarters in order to meet growing demand for its anatomical pathology and molecular profiling services. The new Dallas-area location is three times larger than its previous facility. Located in the high-tech business corridor of Irving, the 172,000-square-foot corporate headquarters features a state-of-the-art molecular diagnostic and anatomic pathology laboratory, housed entirely behind a wall of glass.

Caris has also tripled its square footage in Phoenix by adding a new facility, located in the burgeoning Cotton Center development. The new cutting-edge molecular laboratory space is dedicated to research, the development of new tests for...

IRVING, TX, April 13, 2010 -- Caris Life Sciences™, a leading biosciences company focused on enabling precise and personalized healthcare, today announced the launch of its urologic pathology practice, available through its subsidiary Caris Diagnostics.  The addition of this subspecialty, which is being directed by Rajal B. Shah, M.D., underscores Caris' commitment to providing high quality, academic-caliber diagnostic and theranostic services to a broadening list of subspecialties. Under Dr. Shah's leadership, Caris' urologic pathology experts will also support the development of a revolutionary and proprietary testing platform that will help diagnose and manage prostate cancer patients earlier and less invasively.

"Caris' commitment to precise and personalized healthcare...

IRVING, Texas; March 16, 2010 - Caris Life Sciences™, Inc. - a leading biosciences company focused on enabling precise and personalized healthcare through the highest quality anatomic pathology, molecular profiling, and blood-based diagnostic technologies -  today announced the appointments of Dan Sawyers as Senior Vice President, Chief Accounting Officer, and Greg Kelly, Senior Vice President of Operations.
 
"I am quite pleased to have Dan and Greg join our management team," said Jerry A. Martino, Executive Vice President & Chief Operating Officer of Caris Life Sciences.  "Dan is well-suited to lead our accounting organization as we continue our expansion and accelerate growth, while Greg's leadership and experience will be critical to achieving world-...

IRVING, Texas; January 19th, 2010 – Caris Diagnostics (Caris Dx) today announced that its parent company’s name will change to Caris Life Sciences, Inc., effective immediately. The new name reflects the Company’s successful evolution into a multi-faceted organization that is pioneering precision healthcare, leading to improved patient outcomes and lowered healthcare costs. Caris Life Sciences is focused on five key areas of personalized medicine: Anatomic Pathology, Molecular Profiling, Proprietary Blood-Based Diagnostics, Pharmaceutical Services, and Research and Development.

“The promise of precision healthcare is quickly becoming a reality, thanks in large part to the revolutionary advances in molecular science. Caris Life Sciences reflects our mission of providing quality...